Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,648,066
in 4 filings, $436K under 10b5-1 plans

Net −$1,648,066. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2009-10-13 Tripet Jean-Philippe Director Conversion +489,568 493,102
2009-10-13 Tripet Jean-Philippe Director Conversion · Series E Preferred Stock −489,568 0
2009-10-13 Hood Leroy E. MD PhD Director Conversion +28,880 28,880
2009-10-13 Hood Leroy E. MD PhD Director Conversion · Series C Preferred Stock −28,880 0
2009-10-13 Cable Thomas J. Director Conversion +12,756 32,072
2009-10-13 Cable Thomas J. Director Conversion +14,578 46,650
2009-10-13 Cable Thomas J. Director Conversion +19,253 65,903
2009-10-13 Cable Thomas J. Director Conversion +10,205 76,108
2009-10-13 Cable Thomas J. Director Conversion · Series A Preferred Stock −12,756 0
2009-10-13 Cable Thomas J. Director Conversion · Series B Preferred Stock −14,578 0
2009-10-13 Cable Thomas J. Director Conversion · Series C Preferred Stock −19,253 0
2009-10-13 Cable Thomas J. Director Conversion · Series E Preferred Stock −10,205 0
2009-10-13 Aspiri Ray Director Conversion +53,572 80,542
2009-10-13 Aspiri Ray Director Conversion +30,613 111,155
2009-10-13 Aspiri Ray Director Conversion +20,409 131,564
2009-10-13 Aspiri Ray Director Conversion +5,103 136,667
2009-10-13 Aspiri Ray Director Conversion +10,205 146,872
2009-10-13 Aspiri Ray Director Conversion · Series A Preferred Stock −53,572 0
2009-10-13 Aspiri Ray Director Conversion · Series B Preferred Stock −30,613 0
2009-10-13 Aspiri Ray Director Conversion · Series C Preferred Stock −20,409 0

Page 26 of 27 · 522 trades